Abstract
The surprising observation that direct inoculation of an expression plasmid encoding a foreign protein into the skin of mice resulted in the induction of antibody responses, demonstrated that injection of “naked” DNA could result in antigen expression in an immunogenic form (1). This observation and the subsequent demonstration that intramuscular injections of plasmid DNA encoding influenza nucleoprotein could protect mice against a challenge with live influenza virus have opened up new avenues for vaccine development (2–3). Immunization with plasmid DNA has been shown to activate both humoral and cellular immune responses, including the generation of antigen-specific CD8+ cytotoxic T cells as well as CD4+ T helper cells (4). An increasing number of studies using experimental animal models have demonstrated that plasmid DNA immunization can promote effective immune responses against numerous viruses, including influenza, rabies, HIV, HBV, HCV, and HSV; several bacteria, including: Mycobacterium tuberculosis, Mycoplasma pulmonis, and Borrelia burgdorferi; as well as parasites, such as malaria and leishmania (4). Phase I clinical vaccine trials are currently being performed for HIV, HBV, and influenza virus. With the molecular identification of tumor antigens (5), there has also been increasing interest in the development of DNA-based immunization for cancer. Preclinical studies demonstrate that DNA-based immunizations targeting model tumor antigens such as chicken ovalbumin (6), β-galactosidase (7), or CEA (8) induce protective immune responses leading to rejection of a subsequent, normally lethal challenge with antigen-expressing tumor cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tang, D. C., DeVit, M. J., and Johnston, S. A. (1992) Genetic immunization: a simple method for eliciting an immune response. Nature (Lond.) 356, 152–154.
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11,478–11,482.
Donnelly, J. J., Ulmer, J. B., Shiver, J. W., and Liu, M. A. (1997) DNA vaccines. Ann Rev. Immunol. 15, 617–648.
Boon, T. and Van der Bruggen, P. (1996) Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725–729.
Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D. (1996) DNA-based immunization by in vivo transfectiion of dendritic cells. Nat. Med. 2, 1122–1128.
Irvine, K. R., Rao, R. B., Rosenberg, S. A., and Restifo, N. P. (1996) Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238–245.
Conry, R. M., Widera, G., LoBuglio, A. F., Fuller, J. T., Moore, S. T., Barlow, D. L., Turner, J., Yang, N.-S., and Curiel, D. T. (1996) Selected strategies to augment polynucleotide immunization. Gene Ther. 3, 67–74.
Pardoll, D. M. and Beckerleg, A. M. (1995) Exposing the immunology of naked DNA. Immunity 3, 165–169.
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Felgner, P. L. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468.
Wolff, J. A., Ludtke, J. J., Acsadi, G., Williams, P., and Jani, A. (1992) Logn-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363–369.
Davis, H. L., Whalen, R. G., and Demeneix, B. A. (1993) Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151–159.
Cheng, L., Ziegelhoffer, P. R., and Yang, N.-S. (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455–4459.
Eisenbraun, M. D., Fuller, D. H., and Haynes, J. R. (1993) Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunzation. DNA Cell Biol. 12, 791–797.
Pertmer, T. M., Eisenbraun, M. D., McCabe, D., Prayaga, S. K., Fuller, D. H., and Haynes, J. R. (1995) Gene gun-based nucleic acid immunzation: elicitation of humoral and cytotoxic T-lymphocyte responses following epidermal delivery of nanogram quantites of DNA. Vaccine 13, 1427–1430.
Feltquate, D. M., Heaney, S., Webster, R. G., and Robinson, H. L. (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278–2284.
Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., et al. (1994) Intradermal gene immunization: the possible role fo DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519–9523.
Torres, C. A. T., Iwasaki, A., Barber, B. H., and Robbinson, H. L. (1997) Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158, 4529–4532.
Bos, J. D. and Kapsenberg, M. L. (1993) The skin immune system: progress in cutaneous biology. Immunol. Today 14, 75–78.
Raz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J. A., Roman, M., et al. (1996) Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 91, 9519–9523.
Pertmer, T. M., Roberts, T. R., and Haynes, J. R. (1996) Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 76, 6119–6125.
Cresswell, P. (1993) Antigen processing. Annu. Rev. Immunol. 11, 259–293.
York, I. A. and Rock, K. L. (1996) Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14, 369–396.
Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821.
Rammensee, H.-G. (1995) Chemistry of peptides associated with MHC class I and II molecules. Curr. Opin. Immunol. 7, 85–96.
Boise, L., Minn, A., Noel, P., June, C., Accavitti, M., Lindsten, T., and Thompson, C. (1995) CD28 costimulation can promote T cell survivial by enhancing the expression of Bcl-xL. Immunity 3, 87.
Steinman, R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296.
Cella, M., Sallusto, F., and Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10–16.
Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578–8583.
Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555–1560.
Fu, T.-M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., et al. (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: Requirements for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3, 362–371.
Iwasaki, A., Torres, C. A. T., Ohashi, P. S., Robbinson, H. L., and Barber, B. H. (1997) The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159, 11–14.
Ulmer, J. B., Deck, R. R., Dewitt, C. M., Donnelly, J. J., and Liu, M. A. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59–67.
Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122–1128.
Song, E. C., Lee, V., Surh, C. D., Lynn, A., Brumm, D., Jolly, D. J., et al. (1997) Antigen presentation in retroviral vector-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 94, 1943–1948.
Casares, S., Inaba, K., Brumeanu, T.-D., Steinman, R. M., and Bona, C. A. (1997) Antigen presentation by dendritic cells after immuniation with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186, 1481–1486.
McKinney, E. C. and Streilein, J. W. (1989) On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J. Immunol. 143, 1560–1564.
Timares-Lebow, L., Takashima, A., and Johnston, S. A. (1997) Enhanced immune responses by inoculation of a transfected dendritic cell line (XS106). J. Invest. Derm. 109, 266.
Davis, H. L., Millan, C. L., and Watkins, S. C. (1997) Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4, 181–188.
Xiang, Z. and Ertl, H. C. J. (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129–135.
Conry, R. M., Widera, G., LoBuglio, A. F., Fuller, J. T., Moore, S. T., Barlow, D. L., et al. (1996) Selected strategies to augment polynucleotide immunization. Gene Ther. 3, 67–74.
Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., et al. (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816–826.
Tsuji, T., Hamajima, K., Fukushima, J., Xin, K.-Q., Ishii, N., Aoki, I., et al. (1997) Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid espressing IL-12. J. Immunol. 158, 4008–4013.
Chow, Y. H., Huang, W. L., Chi, W. K., Chu, Y. D., and Tao, M. H. (1997) Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71, 169–178.
Iwasaki, A., Stiernholm, B. J. N., Chan, A. K., Berinstein, N. L., and Barber, B. H. (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591–4601.
Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258.
Chambers, C. A. and Allison, J. P. (1997) Co-stimulation of T cell responses. Curr. Opin. Immunol. 9, 396–404.
Kim, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., et al. (1997) Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotechnol. 15, 641–646.
Levitsky, H. I. (1997) Accessories for naked DNA vaccines. Nat. Biotechnol. 15, 619,620.
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352–354.
Klinman, D. M., Yi, A.-K., Beaucage, S. L., Conover, J., and Krieg, A. M. (1996) CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA 93, 2879–2883.
Ballas, Z. K., Rasmussen, W. L., and Krieg, A. M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynmuclkeotides and bacterial DNA. J. Immunol. 157, 1840–1845.
Klinman, D. M., Yamshchikov, G., and Ishigatsubo, Y. (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158, 3635–3639.
Stacey, K. J., Sweet, M. J., and Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116–2122.
Pisetzki, D. S. (1996) Immune activation by bacterial DNA: a new genetic code. Immunity 5, 303–310.
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghi, A., et al. (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849–854.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte-macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702.
Caux, C., Dezutter-Damboyant C., Schmitt D., Bancherau, J. (1992) GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (Lond.) 360, 258–262.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., et al. (1994) Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83–93.
Reid, C. D. (1997) The dendritic cell lineage in haemopoesis. Br. J. Haematol. 96, 217–223.
Austyn, J. M. (1998) Dendritic cells. Curr. Opin. Hematol. 5, 3–15.
Young, J. W. and Inaba, K. (1996) Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor-immunity. J. Exp. Med. 183, 7–11.
Schuler, G. and Steinman, R. M. (1997) Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183–1187.
Mayordomo, J. I., Zorina, T., Storkus, W. J., Celuzzi, C. M., Falo, L. D., Kast, W. M., et al. (1995) Bone marrow-derived dendritic cells pulsed with tumor peptides elicit protective and therapeutic anti-tumor immunity. Nat. Med. 1, 1297–1302.
Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, S. M., Appasamy, P. M., et al. (1996) Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183, 1357–1365.
Porgador, A., Snyder, D., and Gilboa, E. (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156, 2918–2926.
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., et al. (1996) Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and Th1-associated cytokines. J. Exp. Med. 183, 87–97.
Celluzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., and Falo, L. D. (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283–387.
Bakker, A. B. H., Marland, G., de Boer, A. J., Huijbens, J. F., Danen, E. H. J., Adema, G. J., et al. (1995) Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55, 5330–5334.
van Elsas, A., van der Burg, S. H., van der Minne, C. E., Borghi, M., Mourer, J. S., et al. (1996) Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. Eur. J. Immunol. 26, 1683–1689.
Tjandrawan, T., Mäurer, M. J., Castelli, C., Lotze, M. T., and Storkus, W. J. (1998) Autologous dendritiphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTL in vitro. J. Immunother. 21, 149–157.
Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., et al. (1997) Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213–1221.
Nishioka, Y., Shurin, M., Robbins, P. D., Storkus, W. J., and Lotze, M. T. (1997) Effective tumro immunotherapy using bone marrow-derived dendritic cells genetically engineered to express interleukin 12. J. Immunother. 20, 419.
Szabols, P., Gallardo, H. F., Ciocon, D. H., Sadelein, M., and Young, J. W. (1997) Retrovirally transduced human dendritic cells express a normal phenotype and potent T cell stimulatory capacity. Blood 90, 2160–2167.
Henderson, R. A., Nimgaonkar, M. T., Watkins, S. C., Robbins, P. D., Ball, E. D., and Finn, O. J. (1996) Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 56, 3763–3770.
Reeves, M. E., Royal, R. E., Lam, J. S., Rosenberg, S. A, and Hwu, P. (1996) Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56, 5672–5677.
Aicher, A., Westermann, J., Cayeux, S., Willimsky, G., Daemen, K., Blankenstein, T., et al. (1997) Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25, 39–44.
Smith, C. A., Woodruff, L. S., Kitchingman, G. R., Rooney, C. M. (1996) Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J. Virol. 70, 6733–6740.
Arthur, J. F., Butterfield, L. H., Roth, M. D., Bui, L. A., Kiertscher, S. M., Lau, R., et al. (1997) A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17–25.
Brossart, P., Goldrath, A. W., Butz, E. A., Martin, S., Bevan, M. J. (1997) Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158, 3270–3276.
Ribas, A., Butterfield, L. H., McBride, W. H., Jilani, S. M., Bui, L. A., Vollmer, C. M., et al. (1997) Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57, 2865–2869.
Wan, Y., Bramson, J., Carter, R., Graham, F., and Gauldie, J. (1997) Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum. Gene Ther. 8, 1355–1363.
Song, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., et al. (1997) Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247–1256.
Kim, C. J., Prevette, T., Cormier, J., Overwijk, W., Roden, M., Restifo, N. P., et al. (1997) Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro. J. Immunother. 20, 276–286.
Alijagic, S., Moller, P., Artuc, M., Jurgovsky, K., Czarnetzki, B. M., and Schadendorf, D. (1995) Dendritic cells generated from peripheral blood trans-fected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 25, 3100–3107.
Tüting, T., Wilson, C. C., Martin, D., Kasamon, Y., Rowles, J., Ma, D. I., et al. (1998) Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α. J. Immunol. 160, 1139–1147.
Tüting, T., DeLeo, A., Lotze, M. T., Storkus, W. J. (1997) Bone marrow-derived dendritic cells genetically-modified to express tumor-associated antigens induce antitumor immunity in vivo. Eur. J. Immunol. 27, 2702–2707.
Manickan, E., Kanangat, S., Rouse, R. J. D., Yu, Z., Rouse, B. T. (1997) Enhancement of immune response to naked DNA vaccine by immunization with trans-fected dendritic cells. J. Leukocyte Biol. 61, 125–132.
Martinon, F., Krishnan, S., Lenzen, G., Magne, R., Gomard, E., Guillet, J.-G., et al. (1993) Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23, 1719–1722.
Conry, R. M., LoBuglio, A. F., Wright, M., Sumerel, L., Pike, M. J., Johanning, F., et al. (1995) Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 55, 1397–1400.
Qiu, P., Ziegelhoffer, P., Sun, J., and Yang, N. S. (1996) Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 3, 262–268.
Boczkowski, D., Nair, S. K., Snyder, D., and Gilboa, E. (1996) Dendritic Cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465–472.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Tüting, T., Austyn, J., Storkus, W.J., Falo, L.D. (2000). The Immunology of DNA Vaccines. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:37
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:37
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols